title: Lagophthalmos after facial palsy: current therapeutic options.
abstract: As the facial nerve carries sensory, motor and parasympathetic fibres involved in facial muscle innervation, facial palsy results in functional and cosmetic impairment. It can result from a wide variety of causes like infectious processes, trauma, neoplasms, autoimmune diseases, and most commonly Bell's palsy, but it can also be of iatrogenic origin. The main ophthalmic sequel is lagophthalmos. The increased surface exposure increases the risk of keratitis, corneal ulceration, and potentially loss of vision. Treatment options are wide; some are temporary, some permanent. In addition to gold standard and traditional therapies and procedures, new options are being proposed aiming to improve not only lagophthalmos but also the quality of life of these patients.
authors.affiliation: Instituto de Microcirugia Ocular, Barcelona, Spain.
authors.forename: Luz María
authors.initials: LM
authors.lastname: Vásquez
authors.forename: Ramón
authors.initials: R
authors.lastname: Medel
mesh_terms: D015670:Acupuncture Therapy; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D005141:Eyelid Diseases / Q000209:etiology* / Q000628:therapy*; D005143:Eyelids / Q000294:innervation; D005158:Facial Paralysis / Q000150:complications*; D006801:Humans; D008405:Massage; D009465:Neuromuscular Agents / Q000627:therapeutic use; D013508:Ophthalmologic Surgical Procedures; D012064:Relaxation Therapy
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A